Cargando…
Synthesis of structural analogues of Reversan by ester aminolysis: an access to pyrazolo[1,5-a]pyrimidines from chalcones
Reversan, a multidrug resistance-associated protein (MRP1) inhibitor described more than a decade ago, is a commercial drug (CAS: 313397-13-6) that has a high price and is six to eight times more potent than known drug transporter inhibitors. However, to date, a complete route for synthesizing pyraz...
Autores principales: | Arias-Gómez, Andres, Macías, Mario A., Portilla, Jaime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230348/ https://www.ncbi.nlm.nih.gov/pubmed/37266500 http://dx.doi.org/10.1039/d3ra02553e |
Ejemplares similares
-
Functional Pyrazolo[1,5-a]pyrimidines: Current Approaches in Synthetic Transformations and Uses As an Antitumor Scaffold
por: Arias-Gómez, Andres, et al.
Publicado: (2021) -
Pyrazolo[1,5-a]pyrimidines-based fluorophores: a comprehensive theoretical-experimental study
por: Tigreros, Alexis, et al.
Publicado: (2020) -
Kinetic studies and predictions on the hydrolysis and aminolysis of esters of 2-S-phosphorylacetates
por: Trmčić, Milena, et al.
Publicado: (2010) -
6-Halo-2-pyridone as an efficient organocatalyst for ester aminolysis
por: Yamada, Takeshi, et al.
Publicado: (2021) -
Exploration of Pyrazolo[1,5‐a]pyrimidines as Membrane‐Bound Pyrophosphatase Inhibitors
por: Johansson, Niklas G., et al.
Publicado: (2021)